StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Reiterates Buy Rating on Abbott Labs (ABT) on DD Medical Device Growth Sustainability
March 13, 2026 9:37 AM
UBS analyst Danielle Antalffy reiterated a Buy rating and $158.00 price target on Abbott Labs (NYSE: ABT).The analyst commented, "We ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
